MiR-195 suppresses non-small cell lung cancer by targeting CHEK1

Citations of this article
Mendeley users who have this article in their library.


MiR-195 suppresses tumor growth and is associated with better survival outcomes in several malignancies including non-small cell lung cancer (NSCLC). Our previous study showed high miR-195 plasma levels associated with favorable overall survival of non-smoking women with lung adenocarcinoma. To further elucidate role of miR-195 in NSCLC, we conducted in vitro experiment as well as clinical studies in a cohort of 299 NSCLC samples. We demonstrated that miR-195 expression was lower in tumor tissues and was associated with poor survival outcome. Overexpression of miR-195 suppressed tumor cell growth, migration and invasion. We discovered that CHEK1 was a direct target of miR-195, which decreased CHEK1 expression in lung cancer cells. High expression of CHEK1 in lung tumors was associated with poor overall survival. Our results suggest that miR-195 suppresses NSCLC and predicts lung cancer prognosis.




Liu, B., Qu, J., Xu, F., Guo, Y., Wang, Y., Yu, H., & Qian, B. (2015). MiR-195 suppresses non-small cell lung cancer by targeting CHEK1. Oncotarget, 6(11), 9445–9456. https://doi.org/10.18632/oncotarget.3255

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free